Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Three-dimensional biocompatible ascorbic acid-containing scaffold for bone tissue engineering.

Jian-Ying Zhang1, Bruce A Doll, Eric J Beckman

  • 1Department of Chemical and Petroleum Engineering, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.

Tissue Engineering
|December 13, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Prediction of potential suitable areas for Tenebrionidae in the Alxa Plateau, Northwest China].

Ying yong sheng tai xue bao = The journal of applied ecology·2026
Same author

Doppel as an early-stage biomarker promoting EMT and dissemination in ovarian cancers.

International journal of cancer·2025
Same author

A panel of four autoantibodies to tumour-associated antigens in patients with prostate cancer and its potential for multi-cancer detection.

British journal of cancer·2025
Same author

<i>Tripterygium wilfordii</i> polyglycoside tablets attenuated the progression of hepatocellular carcinoma by targeting IL-6 and downstream signaling pathways in a multi-target manner.

Journal of Asian natural products research·2024
Same author

Retraction notice to "Corrigendum to 'MicroRNA-134 prevents the progression of esophageal squamous cell carcinoma via the PLXNA1-mediated MAPK signalling pathway' [EBioMedicine 46 (2019) 66-78]" [EBioMedicine 55 (2020) 102772].

EBioMedicine·2024
Same author

Retraction notice to 'MicroRNA-134 prevents the progression of esophageal squamous cell carcinoma via the PLXNA1-mediated MAPK signalling pathway' [EBioMedicine 46 (2019) 66-78].

EBioMedicine·2024
Same journal

Change in u.s. Patent infringement law.

Tissue engineering·2009
Same journal

Functional reconstruction of the jaw bones using poly(l-lactide) mesh and autogenic particulate cancellous bone and marrow.

Tissue engineering·2009
Same journal

Effect of the structure of bone morphogenetic protein carriers on ectopic bone regeneration.

Tissue engineering·2009
Same journal

Cross-linking of gelatin with carbodiimides.

Tissue engineering·2009
Same journal

Early treatment of diabetes with porcine islets in a bioartificial pancreas.

Tissue engineering·2009
Same journal

Permeability of filters used for immunoisolation.

Tissue engineering·2009
See all related articles

A new biodegradable polyurethane scaffold containing ascorbic acid (AA) supports bone cell growth and proliferation. This biocompatible material shows promise for bone tissue engineering applications.

Area of Science:

  • Biomaterials Science
  • Tissue Engineering
  • Polymer Chemistry

Background:

  • Developing effective scaffolds is crucial for bone tissue engineering.
  • Biodegradable and biocompatible materials are needed to support cell growth and regeneration.
  • Ascorbic acid (AA) is known to promote bone cell activity.

Purpose of the Study:

  • To develop a novel biodegradable, biocompatible polyurethane scaffold incorporating ascorbic acid (AA) for bone tissue engineering.
  • To evaluate the scaffold's physicochemical properties, degradation behavior, and ability to support bone marrow cell growth and function in vitro.

Main Methods:

  • Synthesis of a polyurethane matrix using lysine-di-isocyanate (LDI), ascorbic acid (AA), glycerol, and polyethylene glycol (PEG).
  • Foaming the prepolymer with water to create a porous structure (100-500 microm pores).

Related Experiment Videos

  • Assessing scaffold degradation, pH changes, cell attachment, viability, proliferation, and differentiation (collagen type I, alkaline phosphatase synthesis) using GFP-MBMCs.

    • Main Results:

    • The LDI-glycerol-PEG-AA matrix is biodegradable, yielding non-pH-altering products like lysine, glycerol, PEG, and AA.
    • The scaffold supports robust in vitro growth, attachment, and viability of mouse bone marrow cells (GFP-MBMCs).
    • Released AA stimulates cell proliferation and synthesis of type I collagen and alkaline phosphatase, with no phenotypic differences compared to polystyrene controls.

    Conclusions:

    • The developed ascorbic acid-containing polyurethane matrix is a promising candidate for bone tissue engineering scaffolds.
    • Its biocompatibility, biodegradability, and ability to promote osteogenic activity make it suitable for regenerative medicine applications.
    • Further research can explore its in vivo efficacy for bone defect repair.